로딩 중…
지수 로딩 중…
휴마시스
205470· KOSDAQ· Health Care· Health Care Equipment & Services
₩2,660-4.32%
2026-06-19
Price Chart
휴마시스-65.27%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 65.64B KRW |
| Revenue | 32.87B KRW |
| Net Income | -16.75B KRW |
| Total Assets | 326.18B KRW |
| Net Assets | 235.48B KRW |
| Employees | 69 |
| Value | |
| P/B | 0.28x |
| P/S | 2.00x |
| Profitability | |
| ROE | -7.11% |
| ROA | -5.14% |
| Op. Margin | -28.74% |
| Revenue Growth | 44.76% |
| Financial Health | |
| Debt Ratio | 138.51% |
| Total Debt | 13.19B KRW |
| Cash | 12.55B KRW |
| Current Ratio | 2.29x |
| Dividend | |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -65.27% |
| 1M Return | -35.83% |
| From 52W High | -67.44% |
| 1Y MDD | -69.41% |
| Trading | |
| Volume | 156,273 shares |
| Foreign Own. | 6.95% |
| Per Share | |
| EPS | -403 KRW |
| BPS | 9,612 KRW |
Company Info
Humasis, established in 2000 as a manufacturer of in-vitro diagnostic medical devices, was listed on the KOSDAQ market in 2017 after merging with HI No. 2 Special Purpose Acquisition Company. The company specializes in the development and production of POCT immunoassay reagent product lines. Through its subsidiary, Billionths, Humasis also manufactures condoms and medical rubber products and operates an entertainment business. It is pursuing business diversification by obtaining approval for new objectives like mineral development and sales at its 2024 regular general meeting of shareholders and is headquartered in Anyang-si, Gyeonggi-do.